Targeted therapies in hepatocellular carcinoma: past, present, and future

被引：0

作者：

Gujarathi, Rushabh ^{[1
]}

Franses, Joseph W. ^{[1
]}

Pillai, Anjana ^{[2
]}

Liao, Chih-Yi ^{[1
]}

机构：

[1] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA

[2] Univ Chicago, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Chicago, IL USA

来源：

FRONTIERS IN ONCOLOGY | 2024年 / 14卷

关键词：

hepatocellular carcinoma; targeted therapy; clinical trials; tyrosine kinase inhibitors; immunotherapy; GROWTH-FACTOR-BETA; RECEPTOR TYROSINE KINASES; CELL LUNG-CANCER; C-MET; TGF-BETA; LIVER-CANCER; SORAFENIB RESISTANCE; ANTITUMOR-ACTIVITY; SIGNALING PATHWAY; 1ST-LINE THERAPY;

D O I：

10.3389/fonc.2024.1432423

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Targeted therapies are the mainstay of systemic therapies for patients with advanced, unresectable, or metastatic hepatocellular carcinoma. Several therapeutic targets, such as c-Met, TGF-beta, and FGFR, have been evaluated in the past, though results from these clinical studies failed to show clinical benefit. However, these remain important targets for the future with novel targeted agents and strategies. The Wnt/beta-catenin signaling pathway, c-Myc oncogene, GPC3, PPT1 are exciting novel targets, among others, currently undergoing evaluation. Through this review, we aim to provide an overview of previously evaluated and potentially novel therapeutic targets and explore their continued relevance in ongoing and future studies for HCC.

引用

页数：16

共 50 条

[1] Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future
Stotz, Michael
Gerger, Armin
Haybaeck, Johannes
Kiesslich, Tobias
Bullock, Marc D.
Pichler, Martin
[J]. ANTICANCER RESEARCH, 2015, 35 (11) : 5737 - 5744
[2] Systemic therapies in hepatocellular carcinoma: present and future
Bertino, Gaetano
Di Carlo, Isidoro
Ardiri, Annalisa
Calvagno, Giuseppe Stefano
Demma, Shirin
Malaguarnera, Giulia
Bertino, Nicoletta
Malaguarnera, Mariano
Toro, Adriana
Malaguarnera, Michele
[J]. FUTURE ONCOLOGY, 2013, 9 (10) : 1533 - 1548
[3] Small hepatocellular carcinoma: Past, present and future
Tang, ZY
[J]. CHINESE MEDICAL JOURNAL, 1996, 109 (01) : 21 - 24
[4] Small hepatocellular carcinoma: past, present and future
Tang Zhaoyou
[J]. CHINESE MEDICAL JOURNAL, 1996, (01)
[5] Targeted therapy of hepatocellular carcinoma: Present and future
Chan, Stephen L.
Yeo, Winnie
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (05) : 862 - 872
[6] Targeted Therapies in Head and Neck Cancer: Past, Present and Future
Rapidis, Alexander D.
Vermorken, Jan B.
Bourhis, Jean
[J]. REVIEWS ON RECENT CLINICAL TRIALS, 2008, 3 (03) : 156 - 166
[7] Systemic treatment of hepatocellular carcinoma: Past, present and future
Esther Una Cidon
[J]. World Journal of Hepatology, 2017, (18) : 797 - 807
[8] Hepatocellular Carcinoma: Its Past, Present, and Future Preface
Reuben, Adrian
[J]. CLINICS IN LIVER DISEASE, 2011, 15 (02) : XIII - XVI
[9] Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future
Kim, Hwi Young
Park, Joong-Won
[J]. LIVER CANCER, 2014, 3 (01) : 9 - 17
[10] Targeted Therapies for Hepatocellular Carcinoma
Villanueva, Augusto
Llovet, Josep M.
[J]. GASTROENTEROLOGY, 2011, 140 (05) : 1410 - 1426

← 1 2 3 4 5 →